IRIS

MELILLO, ROSA MARINA

MELILLO, ROSA MARINA  

DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE  

Mostra records
Risultati 1 - 20 di 148 (tempo di esecuzione: 0.031 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway. 1.1 Articolo in rivista 2002 Pelicci, G; Troglio, F; Bodini, A; Melillo, ROSA MARINA; Pettirossi, V; Coda, L; DE GIUSEPPE, A; Santoro, Massimo; Pelicci, Pg
The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. 1.1 Articolo in rivista 2001 Melillo, ROSA MARINA; Carlomagno, Francesca; DE VITA, Gabriella; Formisano, Pietro; Vecchio, Giancarlo; Fusco, Alfredo; Billaud, M.; Santoro, Massimo
The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. 1.1 Articolo in rivista 1993 Santoro, Massimo; Melillo, ROSA MARINA; Grieco, M.; Berlingieri, M. T.; Vecchio, Giancarlo; Fusco, Alfredo
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 1.1 Articolo in rivista 1998 Carlomagno, F.; Melillo, ROSA MARINA; Visconti, R.; Salvatore, G.; DE VITA, Gabriella; Lupoli, G.; Yu, Y. B.; Jing, S. Q.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M.
Molecular biology of the MEN2 gene 1.1 Articolo in rivista 1998 Santoro, M; Melillo, ROSA MARINA; Carlomagno, Francesca; Visconti, R; DE VITA, Gabriella; Salvatore, G; Lupoli, G; Fusco, Alfredo; Vecchio, G.
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. 1.1 Articolo in rivista 1997 Carlomagno, Francesca; G., Salvatore; A. M., Cirafici; DE VITA, Gabriella; Melillo, ROSA MARINA; V. d., Franciscis; M., Billaud; Fusco, Alfredo; Santoro, Massimo
Molecular heterogeneity of RET loss of function in Hirschsprung's disease 1.1 Articolo in rivista 1996 Carlomagno, Francesca; DE VITA, Gabriella; Berlingieri, Mt; DE FRANCISCIS, V; Melillo, ROSA MARINA; Colantuoni, V; Kraus, Mh; DI FIORE, Pp; Fusco, Alfredo; Santoro, M.
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival 1.1 Articolo in rivista 2000 DE VITA, Gabriella; Melillo, ROSA MARINA; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M.
Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation. 1.1 Articolo in rivista 1995 Santoro, Massimo; M., Grieco; Melillo, ROSA MARINA; Fusco, Alfredo; Vecchio, Giancarlo
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2) 1.1 Articolo in rivista 2003 Carlomagno, Francesca; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). 1.1 Articolo in rivista 2003 Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
Genetic Alterations in differentiated thyroid cancer:what can be expected for gene expression profiling of thyroid carcinomas 1.1 Articolo in rivista 2003 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Castellone, MARIA DOMENICA; Vitagliano, Donata; Guida, Teresa; Vecchio, Giancarlo; Fusco, Alfredo
Molecular heterogeneity of RET loss of function in Hirschsprung's disease. 1.1 Articolo in rivista 1996 Carlomagno, F; DE VITA, G; Berlingieri, Mt; DE FRANCISCIS, V; Melillo, ROSA MARINA; Colantuoni, V; Kraus, Mh; DI FIORE, Pp; Fusco, Alfredo; M., Santoro
Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. 1.1 Articolo in rivista 1994 Grieco, M.; Cerrato, A.; Santoro, Massimo; Fusco, Alfredo; Melillo, ROSA MARINA; Vecchio, Giancarlo
Molecular mechanisms of RET activation in human cancer 2.1 Contributo in volume (Capitolo o Saggio) 2002 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, F; Fusco, Alfredo; Vecchio, Giancarlo
Molecular mechanisms of RET activation in human cancer. 1.1 Articolo in rivista 2002 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Fusco, Alfredo; Vecchio, Giancarlo
Molecular mechanisms of RET activation in human neoplasia. 1.1 Articolo in rivista 1999 Santoro, Massimo; Carlomagno, Francesca; Melillo, ROSA MARINA; M., Billaud; Vecchio, Giancarlo; Fusco, Alfredo
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. 1.1 Articolo in rivista 1990 Grieco, M.; Santoro, Massimo; Berlingieri, M. T.; Melillo, ROSA MARINA; Donghi, R.; Bongarzone, I.; Pierotti, M. A.; Della Porta, G.; Fusco, Alfredo; Vecchio, Giancarlo
Ret-mediated mitogenesis requires Src kinase activity 1.1 Articolo in rivista 1999 Melillo, ROSA MARINA; Barone, Mv; Lupoli, G; Cirafici, Am; Carlomagno, Francesca; Visconti, R; Matoskova, B; DI FIORE, Pp; Vecchio, G; Fusco, Alfredo; Santoro, M.
Ret-mediated mitogenesis requires Src kinase activity. 1.1 Articolo in rivista 1999 Melillo, ROSA MARINA; Barone, Mv; Lupoli, G; Cirafici, Am; Carlomagno, F; Visconti, R; Matoskova, B; DI FIORE, Pp; Vecchio, G; Fusco, Alfredo; Santoro, Massimo